Pacer Advisors, Inc. Deciphera Pharmaceuticals, Inc. Transaction History

Pacer Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$13.58 - $17.36 $13,797 - $17,637	1,016 New	1,016 $15,000
Q2 2021 Jul 21, 2021	SELL	$32.73 - $47.95 $58,848 - $86,214	-1,798 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$40.39 - $56.73 $17,286 - $24,280	-428 Reduced 19.23%	1,798 $81,000
Q4 2020 Jan 20, 2021	BUY	$51.77 - $66.18 $14,909 - $19,059	288 Added 14.86%	2,226 $127,000
Q3 2020 Oct 19, 2020	BUY	$43.8 - $58.16 $84,884 - $112,714	1,938 New	1,938 $99,000
Q4 2018 Feb 13, 2019	SELL	$19.08 - $36.14 $29,459 - $55,800	-1,544 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$33.57 - $42.1 $51,832 - $65,002	1,544 New	1,544 $60,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.